HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heping Yang Selected Research

Methionine Adenosyltransferase

1/2021Deregulated 14-3-3ζ and methionine adenosyltransferase α1 interplay promotes liver cancer tumorigenesis in mice and humans.
11/2020Reciprocal Regulation Between Forkhead Box M1/NF-κB and Methionine Adenosyltransferase 1A Drives Liver Cancer.
1/2016Deregulated methionine adenosyltransferase α1, c-Myc, and Maf proteins together promote cholangiocarcinoma growth in mice and humans(‡).
4/2015Methionine adenosyltransferase 2B-GIT1 complex serves as a scaffold to regulate Ras/Raf/MEK1/2 activity in human liver and colon cancer cells.
1/2015S-Adenosylmethionine and methylthioadenosine inhibit β-catenin signaling by multiple mechanisms in liver and colon cancer.
8/2013Methionine adenosyltransferase 2B, HuR, and sirtuin 1 protein cross-talk impacts on the effect of resveratrol on apoptosis and growth in liver cancer cells.
1/2013MicroRNAs regulate methionine adenosyltransferase 1A expression in hepatocellular carcinoma.
6/2011Insulin-like growth factor 1 activates methionine adenosyltransferase 2A transcription by multiple pathways in human colon cancer cells.
12/2010Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice.
5/2010Forced expression of methionine adenosyltransferase 1A in human hepatoma cells suppresses in vivo tumorigenicity in mice.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heping Yang Research Topics

Disease

16Neoplasms (Cancer)
05/2021 - 04/2008
12Liver Neoplasms (Liver Cancer)
01/2021 - 03/2007
9Carcinogenesis
01/2021 - 02/2008
9Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2008
7Cholangiocarcinoma
01/2021 - 07/2011
7Lung Neoplasms (Lung Cancer)
06/2018 - 08/2005
6Colonic Neoplasms (Colon Cancer)
04/2015 - 07/2007
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2018 - 12/2009
5Cholestasis
01/2018 - 03/2009
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2013 - 08/2005
4Adenocarcinoma of Lung
10/2013 - 06/2008
3COVID-19
03/2021 - 01/2021
3Infections
01/2020 - 11/2003
3Neoplasm Metastasis (Metastasis)
01/2017 - 04/2012
3Liver Diseases (Liver Disease)
01/2015 - 04/2008
3Fibrosis (Cirrhosis)
10/2012 - 04/2008
3Adenocarcinoma
01/2010 - 08/2005
2Inflammation (Inflammations)
01/2013 - 02/2012
1Type 2 Diabetes Mellitus (MODY)
03/2021
1Mouth Neoplasms (Oral Cancer)
12/2019
1Male Infertility (Male Sterility)
01/2018
1Pneumonia (Pneumonitis)
12/2017
1Nausea
12/2017
1Vomiting
12/2017
1Neutropenia
12/2017
1Photosensitivity Disorders (Photodermatitis)
04/2015
1Colitis-Associated Neoplasms
01/2015
1Lymphatic Metastasis
10/2013
1Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)
10/2012
1Eczema
04/2012

Drug/Important Bio-Agent (IBA)

13Methionine AdenosyltransferaseIBA
01/2021 - 07/2007
11Proteins (Proteins, Gene)FDA Link
11/2020 - 08/2005
6Small Interfering RNA (siRNA)IBA
02/2018 - 12/2009
5Messenger RNA (mRNA)IBA
01/2019 - 07/2007
5S-Adenosylmethionine (Ademetionine)IBA
01/2016 - 07/2007
4EnzymesIBA
12/2017 - 10/2005
3ProhibitinsIBA
01/2019 - 12/2010
3Pemetrexed (MTA)FDA Link
01/2015 - 07/2007
2NF-kappa B (NF-kB)IBA
11/2020 - 10/2005
2Pharmaceutical PreparationsIBA
09/2020 - 12/2017
2Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2019 - 10/2005
2DNA (Deoxyribonucleic Acid)IBA
06/2018 - 12/2011
2Cisplatin (Platino)FDA LinkGeneric
02/2018 - 12/2011
2Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2018 - 07/2011
2Levofloxacin (Levaquin)FDA Link
12/2017 - 01/2012
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2015 - 06/2013
2MicroRNAs (MicroRNA)IBA
01/2013 - 07/2011
2Interleukin-6 (Interleukin 6)IBA
01/2013 - 02/2012
2P-SelectinIBA
10/2012 - 04/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2012 - 10/2005
2Cyclin D1IBA
07/2011 - 03/2009
2Glutathione (Reduced Glutathione)IBA
04/2010 - 06/2009
2LeptinIBA
03/2010 - 02/2008
2MitogensIBA
07/2007 - 03/2007
1Metformin (Glucophage)FDA LinkGeneric
03/2021
1InterferonsIBA
03/2021
1Ribavirin (Virazole)FDA LinkGeneric
03/2021
1Estrogens (Estrogen)FDA Link
01/2021
1T0901317IBA
11/2020
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1CarbonIBA
12/2019
1Interleukin-8 (Interleukin 8)IBA
01/2019
1MethyltransferasesIBA
06/2018
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
02/2018
1SurvivinIBA
02/2018
1Glyphosate (Roundup)IBA
01/2018
1HerbicidesIBA
01/2018
1obeticholic acidIBA
01/2018
1nemonoxacinIBA
12/2017
1polysialic acidIBA
01/2017
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
01/2017
1Lithocholic AcidIBA
01/2016
1Maf Transcription FactorsIBA
01/2016
1VimentinIBA
11/2015
1Cadherins (E-Cadherin)IBA
11/2015
1CurcuminIBA
11/2015
1bisdemethoxycurcuminIBA
11/2015
1PowdersIBA
04/2015
1CateninsIBA
01/2015
1Glycogen Synthase KinasesIBA
01/2015
1clonidine-displacing substance (ClDS)IBA
01/2015
1Inflammation MediatorsIBA
01/2015
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
10/2013
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2013
1Tissue Inhibitor of Metalloproteinase-2IBA
10/2013
1Tissue Inhibitor of Metalloproteinase-1IBA
10/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2013
1ResveratrolIBA
08/2013
1Sirtuin 1IBA
08/2013
1AntioxidantsIBA
01/2013
1P-selectin ligand proteinIBA
10/2012
1N 30IBA
10/2012
1IntegrinsIBA
04/2012
1Penicillin G Benzathine (Benzathine Benzylpenicillin)FDA Link
04/2012
1Betamethasone (Celestone)FDA Link
04/2012

Therapy/Procedure

4Therapeutics
03/2021 - 04/2012
4Ligation
01/2018 - 07/2011
2Immunotherapy
05/2021 - 09/2020
1Drug Therapy (Chemotherapy)
01/2015
1Chemoprevention
01/2015